Brihad Abhyankar
About
In The Last Decade
Brihad Abhyankar
35 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Genetics 1.8k
- Epidemiology 1.4k
- Immunology 585
- Surgery 543
- Public Health, Environmental and Occupational Health 172
Countries citing papers authored by Brihad Abhyankar
This map shows the geographic impact of Brihad Abhyankar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brihad Abhyankar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brihad Abhyankar more than expected).
Fields of papers citing papers by Brihad Abhyankar
This network shows the impact of papers produced by Brihad Abhyankar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brihad Abhyankar. The network helps show where Brihad Abhyankar may publish in the future.
Co-authorship network of co-authors of Brihad Abhyankar
This figure shows the co-authorship network connecting the top 25 collaborators of Brihad Abhyankar. A scholar is included among the top collaborators of Brihad Abhyankar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brihad Abhyankar. Brihad Abhyankar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis breakdown → | 461 |
| 3 | 18 | |
| 4 | 68 | |
| 5 | The safety of vedolizumab for ulcerative colitis and Crohn's disease breakdown → | 563 |
| 6 | 201 | |
| 7 | 158 | |
| 8 | 167 | |
| 9 | 135 | |
| 10 | 1 | |
| 11 | 168 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | 1 | |
| 16 | 4 | |
| 17 | 8 | |
| 18 | 22 | |
| 19 | 25 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.